Orbimed Advisors as of March 31, 2019
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 119 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 7.2 | $467M | 4.0M | 117.70 | |
| Tricida | 6.5 | $421M | 11M | 38.62 | |
| Clementia | 4.2 | $272M | 10M | 26.10 | |
| Alexion Pharmaceuticals | 4.1 | $265M | 2.0M | 135.18 | |
| Alector (ALEC) | 3.8 | $247M | 13M | 18.72 | |
| Boston Scientific Corporation (BSX) | 3.4 | $222M | 5.8M | 38.38 | |
| Merck & Co (MRK) | 3.3 | $214M | 2.6M | 83.17 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.7 | $176M | 955k | 183.95 | |
| Neurocrine Biosciences (NBIX) | 2.5 | $162M | 1.8M | 88.10 | |
| Wright Medical Group Nv | 2.2 | $140M | 4.4M | 31.45 | |
| Mylan Nv | 2.1 | $138M | 4.9M | 28.34 | |
| Edwards Lifesciences (EW) | 2.1 | $137M | 715k | 191.33 | |
| Thermo Fisher Scientific (TMO) | 1.9 | $122M | 447k | 273.72 | |
| Intuitive Surgical (ISRG) | 1.9 | $120M | 210k | 570.58 | |
| Guardant Health (GH) | 1.8 | $118M | 1.5M | 76.70 | |
| Synthorx | 1.7 | $108M | 5.3M | 20.37 | |
| Sarepta Therapeutics (SRPT) | 1.5 | $99M | 828k | 119.19 | |
| Anthem (ELV) | 1.4 | $93M | 325k | 286.98 | |
| Bausch Health Companies (BHC) | 1.4 | $92M | 3.7M | 24.70 | |
| Regeneron Pharmaceuticals (REGN) | 1.4 | $88M | 215k | 410.62 | |
| Principia Biopharma | 1.4 | $89M | 2.6M | 34.00 | |
| Deciphera Pharmaceuticals (DCPH) | 1.3 | $84M | 3.6M | 23.21 | |
| Inspire Med Sys (INSP) | 1.3 | $84M | 1.5M | 56.78 | |
| Immunomedics | 1.3 | $82M | 4.3M | 19.21 | |
| eHealth (EHTH) | 1.1 | $74M | 1.2M | 62.34 | |
| Puma Biotechnology (PBYI) | 1.1 | $73M | 1.9M | 38.79 | |
| Audentes Therapeutics | 1.1 | $71M | 1.8M | 39.02 | |
| Illumina (ILMN) | 1.1 | $71M | 227k | 310.69 | |
| Clovis Oncology | 1.1 | $70M | 2.8M | 24.82 | |
| Exelixis (EXEL) | 1.0 | $67M | 2.8M | 23.80 | |
| Teva Pharmaceutical Industries (TEVA) | 1.0 | $64M | 4.1M | 15.68 | |
| Agilent Technologies Inc C ommon (A) | 1.0 | $64M | 799k | 80.38 | |
| Logicbio Therapeutics | 1.0 | $64M | 6.5M | 9.88 | |
| Ptc Therapeutics I (PTCT) | 0.9 | $57M | 1.5M | 37.64 | |
| Bristol Myers Squibb (BMY) | 0.9 | $57M | 1.2M | 47.71 | |
| Humana (HUM) | 0.9 | $56M | 210k | 266.00 | |
| Iovance Biotherapeutics (IOVA) | 0.8 | $53M | 5.5M | 9.51 | |
| Avedro | 0.8 | $52M | 4.2M | 12.27 | |
| Endo International (ENDPQ) | 0.8 | $50M | 6.2M | 8.03 | |
| Abbott Laboratories (ABT) | 0.8 | $49M | 615k | 79.94 | |
| Myokardia | 0.7 | $47M | 907k | 51.99 | |
| Argenx Se (ARGX) | 0.7 | $45M | 361k | 124.84 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.7 | $44M | 1.9M | 22.76 | |
| Meiragtx Holdings (MGTX) | 0.7 | $42M | 2.5M | 17.23 | |
| Zai Lab (ZLAB) | 0.6 | $41M | 1.4M | 29.51 | |
| Cigna Corp (CI) | 0.6 | $41M | 253k | 160.82 | |
| Tandem Diabetes Care (TNDM) | 0.6 | $40M | 631k | 63.50 | |
| Arvinas Ord (ARVN) | 0.6 | $40M | 2.7M | 14.76 | |
| Viewray (VRAYQ) | 0.6 | $38M | 5.1M | 7.39 | |
| Beigene (BGNE) | 0.6 | $37M | 283k | 132.00 | |
| Takeda Pharmaceutical (TAK) | 0.6 | $36M | 1.8M | 20.37 | |
| Apellis Pharmaceuticals (APLS) | 0.6 | $36M | 1.8M | 19.51 | |
| Obseva Sa | 0.5 | $33M | 2.6M | 12.79 | |
| Restorbio | 0.5 | $33M | 4.8M | 6.82 | |
| Prothena (PRTA) | 0.5 | $30M | 2.4M | 12.13 | |
| Genfit S A ads (GNFT) | 0.5 | $30M | 1.2M | 24.00 | |
| BioMarin Pharmaceutical (BMRN) | 0.5 | $29M | 327k | 88.83 | |
| Gilead Sciences (GILD) | 0.5 | $29M | 444k | 65.01 | |
| Kala Pharmaceuticals | 0.4 | $29M | 3.4M | 8.27 | |
| Celgene Corporation | 0.4 | $28M | 295k | 94.34 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.4 | $28M | 2.0M | 13.87 | |
| Xtant Med Hldgs (XTNT) | 0.4 | $28M | 9.2M | 3.05 | |
| Heron Therapeutics (HRTX) | 0.4 | $26M | 1.1M | 24.44 | |
| Caredx (CDNA) | 0.4 | $26M | 828k | 31.52 | |
| Cymabay Therapeutics | 0.4 | $25M | 1.9M | 13.28 | |
| Alpine Immune Sciences (ALPN) | 0.4 | $25M | 3.7M | 6.86 | |
| Corvus Pharmaceuticals (CRVS) | 0.4 | $24M | 6.0M | 4.02 | |
| Amgen (AMGN) | 0.4 | $23M | 122k | 189.98 | |
| Harpoon Therapeutics | 0.4 | $23M | 2.4M | 9.47 | |
| Enanta Pharmaceuticals (ENTA) | 0.3 | $22M | 233k | 95.52 | |
| Natera (NTRA) | 0.3 | $22M | 1.1M | 20.62 | |
| Rhythm Pharmaceuticals (RYTM) | 0.3 | $22M | 787k | 27.41 | |
| Biogen Idec (BIIB) | 0.3 | $21M | 88k | 236.39 | |
| Aurinia Pharmaceuticals (AUPH) | 0.3 | $21M | 3.1M | 6.50 | |
| Assembly Biosciences | 0.3 | $20M | 996k | 19.69 | |
| Foamix Pharmaceuticals | 0.3 | $20M | 5.2M | 3.75 | |
| Si-bone (SIBN) | 0.3 | $19M | 985k | 18.84 | |
| Sinovac Biotech (SVA) | 0.3 | $18M | 2.8M | 6.47 | |
| Novo Nordisk A/S (NVO) | 0.3 | $17M | 330k | 52.31 | |
| Aeglea Biotherapeutics | 0.3 | $17M | 2.2M | 8.05 | |
| Dex (DXCM) | 0.3 | $17M | 139k | 119.10 | |
| Amarin Corporation (AMRN) | 0.3 | $17M | 818k | 20.76 | |
| Verrica Pharmaceuticals (VRCA) | 0.2 | $16M | 1.5M | 10.81 | |
| Synlogic | 0.2 | $15M | 2.0M | 7.59 | |
| Spdr S&p 500 Etf (SPY) | 0.2 | $14M | 50k | 282.48 | |
| Nabriva Therapeutics | 0.2 | $11M | 4.6M | 2.44 | |
| Constellation Pharmceticls I | 0.2 | $11M | 836k | 13.55 | |
| Stryker Corporation (SYK) | 0.2 | $11M | 54k | 197.52 | |
| Novus Therapeutics | 0.2 | $10M | 2.5M | 4.02 | |
| Scpharmaceuticals (SCPH) | 0.2 | $10M | 3.4M | 3.00 | |
| Mersana Therapeutics (MRSN) | 0.1 | $9.9M | 1.9M | 5.26 | |
| Verona Pharma Plc ads (VRNA) | 0.1 | $8.1M | 1.3M | 6.50 | |
| Amicus Therapeutics (FOLD) | 0.1 | $7.0M | 518k | 13.60 | |
| Wave Life Sciences (WVE) | 0.1 | $7.0M | 180k | 38.85 | |
| Selecta Biosciences (RNAC) | 0.1 | $6.8M | 2.9M | 2.37 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $6.4M | 635k | 10.16 | |
| Adverum Biotechnologies | 0.1 | $6.5M | 1.2M | 5.24 | |
| Intellia Therapeutics (NTLA) | 0.1 | $6.4M | 378k | 17.08 | |
| Spero Therapeutics (SPRO) | 0.1 | $6.5M | 508k | 12.81 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $5.8M | 1.4M | 4.30 | |
| Invitae (NVTAQ) | 0.1 | $5.2M | 222k | 23.42 | |
| Cti Biopharma | 0.1 | $4.9M | 5.0M | 0.97 | |
| Athenex | 0.1 | $5.3M | 430k | 12.25 | |
| Menlo Therapeutics | 0.1 | $5.0M | 634k | 7.85 | |
| X4 Pharmaceuticals (XFOR) | 0.1 | $5.4M | 312k | 17.41 | |
| Aerpio Pharmaceuticals | 0.1 | $4.7M | 5.2M | 0.90 | |
| Avrobio Ord (AVRO) | 0.1 | $4.4M | 199k | 22.05 | |
| Nuvectra | 0.1 | $3.9M | 350k | 11.01 | |
| Realm Therapeutics | 0.1 | $3.9M | 1.0M | 3.85 | |
| Aerie Pharmaceuticals | 0.0 | $2.8M | 58k | 47.50 | |
| Kalvista Pharmaceuticals (KALV) | 0.0 | $2.6M | 91k | 28.62 | |
| Marinus Pharmaceuticals | 0.0 | $1.7M | 398k | 4.18 | |
| Krystal Biotech (KRYS) | 0.0 | $1.9M | 59k | 32.90 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.0 | $1.4M | 2.0M | 0.69 | |
| Syndax Pharmaceuticals (SNDX) | 0.0 | $1.1M | 212k | 5.25 | |
| Biolinerx Ltd-spons | 0.0 | $447k | 1.0M | 0.43 | |
| Sierra Oncology | 0.0 | $542k | 317k | 1.71 | |
| Recro Pharma (SCTL) | 0.0 | $255k | 44k | 5.86 | |
| Medigus | 0.0 | $44k | 15k | 2.93 |
